The global Drug Delivery Systems market in biomaterials is projected to experience significant growth, fueled by increasing prevalence of chronic diseases, technological advancements, and the rise in biologics and biosimilars in biomaterials. According to a report by Grand View Research, the market size is expected to reach approximately $900.3 billion by 2028, growing at a CAGR of 5.4% from 2021. The development of targeted drug delivery systems and nanotechnology has particularly sparked interest. However, stringent regulatory frameworks and high development costs pose challenges. Despite these hurdles, ongoing R&D in personalized medicine and combination therapies present promising opportunities in this dynamic market.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
